ArticleNeuro-oncology2025

Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?

Mariëtte E G Kranendonk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.